Clinical Trial Update: PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin. [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and effectiveness of low-molecular-weight heparin versus placebo bridging therapy for patients on long-term warfarin requiring te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Stroke | Phase 3 | Status: UNKNOWN